Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,016.00    0.00 (0.00%)
Bid:
1,022.00
Ask:
1,026.00
Spread: 4.00 (0.391%)
Market Cap: £145.79b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Capital increase timeline

27 Oct 2020 17:59

RNS Number : 3972D
Banco Santander S.A.
27 October 2020
 

 

 

Banco Santander, S.A. ("Banco Santander" or the "Bank" or "Santander"), pursuant to the provisions of the Spanish Securities Market Act (Ley del Mercado de Valores), hereby announces the following:

 

OTHER RELEVANT INFORMATION

 

At the general meeting held today, shareholders passed a resolution to increase share capital against reserves (hereinafter, the 'Capital Increase'). If approved by the Bank's Executive Committee, the Capital Increase will be used to pay out approximately 0.10 euros per share in the form of newly issued shares as announced on 29 July 2020. The timeline for the Capital Increase is as follows:

· 12 November 2020. Execution of the Capital Increase and announcement of the number of rights required to receive one share.

· 13 November 2020 (23:59 hours CET). Reference date to participate in the Capital Increase (last trading date). Those who acquired their shares in the Bank by this date (inclusive) and appear as shareholders in the registries of Iberclear at 23:59 CET on 17 November 2020, will be entitled to take part in the Capital Increase.

· 16 November 2020. Start of the rights trading period. Santander shares will trade ex-coupon (ex-date).

· 30 November 2020. End of the rights trading period.

· 4-10 December 2020. Procedures for registering the Capital Increase and admitting new shares to trading on Spanish securities markets.

· 11 December 2020. Start of ordinary trading of the new shares on Spanish securities markets, subject to required authorisation.[1] Shareholders receive their new shares.

 

Boadilla del Monte (Madrid), 27 October, 2020

 

 

[1] Estimated date. The Bank shall also request that the new shares be admitted to trading on any foreign securities markets where it is listed.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRBDGRUDDGGR
Date   Source Headline
12th Feb 20263:02 pmRNSBuyback programme: transactions 4-11Feb
10th Feb 20265:09 pmRNSChanges to the presentation of Group’s information
5th Feb 20265:34 pmRNSDirector/PDMR Shareholding
5th Feb 20265:32 pmRNSDirector/PDMR Shareholding
4th Feb 20267:43 amRNSCommencement of a program to repurchase own shares
4th Feb 20267:00 amRNS2025 Results - Press release
4th Feb 20267:00 amRNS2025 Financial report & Earnings presentation
4th Feb 20267:00 amRNSNotice of presentation to analysts
3rd Feb 20266:28 pmRNSSantander to acquire Webster Bank for $12.2 bn
2nd Feb 202612:11 pmRNSTotal Voting Rights
28th Jan 202610:03 amRNSNotice of 2025 Results Presentation
13th Jan 20265:28 pmRNSDirector/PDMR Shareholding
31st Dec 202510:46 amRNSTotal Voting Rights
31st Dec 202510:46 amRNSTotal Voting Rights
30th Dec 20254:32 pmRNSFurther re Capital reduction
30th Dec 20254:32 pmRNSFurther re Capital reduction
23rd Dec 20256:23 pmRNSDirector/PDMR Shareholding
23rd Dec 20256:23 pmRNSDirector/PDMR Shareholding
23rd Dec 20256:21 pmRNSDirector/PDMR Shareholding
23rd Dec 20256:21 pmRNSDirector/PDMR Shareholding
23rd Dec 20254:42 pmRNSTotal Voting Rights
23rd Dec 20254:42 pmRNSTotal Voting Rights
23rd Dec 202511:08 amRNSCapital reduction following completion of program
23rd Dec 202511:08 amRNSCapital reduction following completion of program
19th Dec 20253:31 pmRNSDirector/PDMR Shareholding
19th Dec 20253:31 pmRNSDirector/PDMR Shareholding
18th Dec 202511:11 amRNSBuyback programme: transactions 11-17dec
11th Dec 20255:53 pmRNSDirector/PDMR Shareholding
11th Dec 202511:07 amRNSBuyback programme: transactions 4-10dec
4th Dec 202511:05 amRNSBuyback programme: transactions 27nov-3dec
2nd Dec 20257:00 amRNSCompletion of an accelerated placement of shares
1st Dec 20254:42 pmRNSTotal Voting Rights
27th Nov 202511:07 amRNSBuyback programme: transactions 20-26nov
21st Nov 20252:09 pmRNSDirector/PDMR Shareholding
20th Nov 202511:08 amRNSBuyback programme: transactions 13-19 nov
17th Nov 20259:13 amRNSOptional Early Redemption ISIN XS2102912966
13th Nov 202511:10 amRNSBuyback programme: transactions 6-12nov
7th Nov 20254:58 pmRNSDirector/PDMR Shareholding
7th Nov 20254:56 pmRNSDirector/PDMR Shareholding
6th Nov 202511:08 amRNSBuyback programme: transactions 30Oct-5nov
6th Nov 202510:55 amRNSDirector/PDMR Shareholding
31st Oct 202511:45 amRNSTotal Voting Rights
31st Oct 20257:00 amRNSSREP Capital Requirements 2025
30th Oct 202511:06 amRNSBuyback programme: transactions 23-29Oct
29th Oct 20257:00 amRNS3Q 2025 Financial report & Earnings presentation
29th Oct 20257:00 amRNS3Q 2025 Results - Press release
23rd Oct 202511:07 amRNSBuyback programme: transactions 16-22Oct
22nd Oct 202511:11 amRNSThird Quarter 2025 Results Notice
16th Oct 202511:12 amRNSBuyback programme: transactions 9-15Oct
9th Oct 202511:05 amRNSBuyback programme: transactions 2-8Oct

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.